12:00 AM
May 17, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

MDRNA preclinical data

In a mouse model of orthotopic bladder cancer, intravesical delivery of UsiRNAs targeting v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS)...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >